المؤلفون: Rao AG; DOW Medical College, Baba-e-urdu Road, Saddar, Karachi, Pakistan. Electronic address: asadgulrao123@gmail.com.

المصدر: International immunopharmacology [Int Immunopharmacol] 2024 Jun 30; Vol. 135, pp. 112265. Date of Electronic Publication: 2024 May 22.

نوع المنشور: Editorial; Letter

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-1705 (Electronic) Linking ISSN: 15675769 NLM ISO Abbreviation: Int Immunopharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Agammaglobulinaemia Tyrosine Kinase*/antagonists & inhibitors , Agammaglobulinaemia Tyrosine Kinase*/metabolism , Multiple Sclerosis*/drug therapy , Multiple Sclerosis*/immunology , Protein Kinase Inhibitors*/therapeutic use , Protein Kinase Inhibitors*/pharmacology, Humans ; Animals ; Tyrosine Kinase Inhibitors

المؤلفون: Yin S; Department of Neuro-Oncology, Cancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China., Zheng X; Department of Neuro-Oncology, Cancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China., Zhang W; Department of Neuro-Oncology, Cancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China., Zhao H; Department of Neuro-Oncology, Cancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China., Zhang R; Department of Neuro-Oncology, Cancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China., Li W; Department of Neuro-Oncology, Cancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China. liwenbin@ccmu.edu.cn., Chen F; Department of Neuro-Oncology, Cancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China. chenfeng@bjtth.org.

المصدر: Annals of hematology [Ann Hematol] 2024 Jul; Vol. 103 (7), pp. 2231-2244. Date of Electronic Publication: 2023 Oct 16.

نوع المنشور: Systematic Review; Journal Article; Meta-Analysis; Review

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Lymphocytic, Chronic, B-Cell*/drug therapy , Protein Kinase Inhibitors*/therapeutic use , Protein Kinase Inhibitors*/adverse effects , Agammaglobulinaemia Tyrosine Kinase*/antagonists & inhibitors, Humans ; Treatment Outcome ; Pyrimidines/therapeutic use ; Pyrimidines/adverse effects ; Tyrosine Kinase Inhibitors ; Benzamides ; Piperidines ; Pyrazines ; Pyrazoles

المؤلفون: Liu WN; Department of Medicine, Tri-Service General Hospital, Taipei 114, Taiwan., Dai MS; Division of Hematology/Oncology, Department of Internal Medicine, National Defense Medical Center, Taipei 114, Taiwan., Lin F; Community Care, Minnesota Oncology, Minneapolis, MN 55404, United States., Lin GM; Department of Medicine, Hualien Armed Forces General Hospital, Hualien City 970, Taiwan. farmer507@yahoo.com.tw.

المصدر: World journal of gastroenterology [World J Gastroenterol] 2024 Jun 07; Vol. 30 (21), pp. 2748-2750.

نوع المنشور: Editorial

بيانات الدورية: Publisher: Baishideng Publishing Group Country of Publication: United States NLM ID: 100883448 Publication Model: Print Cited Medium: Internet ISSN: 2219-2840 (Electronic) Linking ISSN: 10079327 NLM ISO Abbreviation: World J Gastroenterol Subsets: MEDLINE

مواضيع طبية MeSH: Agammaglobulinaemia Tyrosine Kinase*/antagonists & inhibitors , Virus Activation*/drug effects , Hepatitis B virus*/drug effects , Protein Kinase Inhibitors*/therapeutic use , Protein Kinase Inhibitors*/adverse effects, Humans ; Antiviral Agents/therapeutic use ; Hepatitis B/drug therapy ; Hepatitis B/virology ; Risk Assessment ; Hepatitis B, Chronic/drug therapy ; Hepatitis B, Chronic/virology ; Hematologic Neoplasms/drug therapy ; Hematologic Neoplasms/virology ; Tyrosine Kinase Inhibitors

المؤلفون: Zhao Y; Toronto General Hospital Research Institute, University Health Network, Toronto, ON M5G 2M1, Canada., Chakraborty P; Toronto General Hospital Research Institute, University Health Network, Toronto, ON M5G 2M1, Canada., Tomassetti J; Toronto General Hospital Research Institute, University Health Network, Toronto, ON M5G 2M1, Canada., Subha T; Toronto General Hospital Research Institute, University Health Network, Toronto, ON M5G 2M1, Canada., Massé S; Toronto General Hospital Research Institute, University Health Network, Toronto, ON M5G 2M1, Canada., Thavendiranathan P; Toronto General Hospital Research Institute, University Health Network, Toronto, ON M5G 2M1, Canada.; Ted Rogers Centre for Heart Research, Toronto, ON M5G 1M1, Canada., Billia F; Toronto General Hospital Research Institute, University Health Network, Toronto, ON M5G 2M1, Canada.; Ted Rogers Centre for Heart Research, Toronto, ON M5G 1M1, Canada., Lai PFH; Toronto General Hospital Research Institute, University Health Network, Toronto, ON M5G 2M1, Canada., Abdel-Qadir H; Toronto General Hospital Research Institute, University Health Network, Toronto, ON M5G 2M1, Canada.; Ted Rogers Centre for Heart Research, Toronto, ON M5G 1M1, Canada.; Women's College Hospital, Toronto, ON M5S 1B2, Canada., Nanthakumar K; Toronto General Hospital Research Institute, University Health Network, Toronto, ON M5G 2M1, Canada.

المصدر: International journal of molecular sciences [Int J Mol Sci] 2024 Jun 05; Vol. 25 (11). Date of Electronic Publication: 2024 Jun 05.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Benzamides*/pharmacology , Benzamides*/therapeutic use , Rats, Sprague-Dawley* , Agammaglobulinaemia Tyrosine Kinase*/metabolism , Agammaglobulinaemia Tyrosine Kinase*/antagonists & inhibitors , Arrhythmias, Cardiac*/metabolism , Arrhythmias, Cardiac*/chemically induced , Piperidines*/pharmacology , Piperidines*/therapeutic use, Animals ; Male ; Rats ; Action Potentials/drug effects ; Ventricular Remodeling/drug effects ; Protein Kinase Inhibitors/pharmacology ; Pyrazines/pharmacology ; Calcium/metabolism ; Adenine/analogs & derivatives ; Adenine/pharmacology ; Adenine/adverse effects ; Sarcoplasmic Reticulum Calcium-Transporting ATPases/metabolism ; Heart Ventricles/drug effects ; Heart Ventricles/metabolism ; Heart Ventricles/physiopathology ; Pyrimidines/pharmacology ; Calcium Signaling/drug effects ; Pyrazoles/pharmacology ; Tyrosine Kinase Inhibitors

المؤلفون: Patel JN; Department of Cancer Pharmacology and Pharmacogenomics, Atrium Health Levine Cancer Institute, Charlotte, NC 28204, USA.; Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC 27157, USA., Singh J; Sanger Heart and Vascular Institute, Atrium Health, Charlotte, NC 28204, USA., Ghosh N; Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC 27157, USA.; Department of Hematologic Malignancies and Blood Disorders, Atrium Health Levine Cancer Institute, Charlotte, NC 28204, USA.

المصدر: Oncotarget [Oncotarget] 2024 Jun 03; Vol. 15, pp. 355-359. Date of Electronic Publication: 2024 Jun 03.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Electronic Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE

مواضيع طبية MeSH: Agammaglobulinaemia Tyrosine Kinase*/antagonists & inhibitors , Agammaglobulinaemia Tyrosine Kinase*/genetics , Protein Kinase Inhibitors*/adverse effects , Cardiotoxicity*/etiology , Leukemia, Lymphocytic, Chronic, B-Cell*/drug therapy , Leukemia, Lymphocytic, Chronic, B-Cell*/genetics , Piperidines*/adverse effects , Piperidines*/therapeutic use, Humans ; Adenine/analogs & derivatives ; Adenine/adverse effects ; Risk Assessment ; Pyrimidines/adverse effects ; Pyrazoles/adverse effects ; Biomarkers ; Polymorphism, Single Nucleotide ; KCNQ1 Potassium Channel/genetics ; Tyrosine Kinase Inhibitors

المؤلفون: Krämer J; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany., Wiendl H

المصدر: Current opinion in neurology [Curr Opin Neurol] 2024 Jun 01; Vol. 37 (3), pp. 237-244. Date of Electronic Publication: 2024 Mar 27.

نوع المنشور: Journal Article; Review; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9319162 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-6551 (Electronic) Linking ISSN: 13507540 NLM ISO Abbreviation: Curr Opin Neurol Subsets: MEDLINE

مواضيع طبية MeSH: Agammaglobulinaemia Tyrosine Kinase*/antagonists & inhibitors , Agammaglobulinaemia Tyrosine Kinase*/metabolism , Protein Kinase Inhibitors*/therapeutic use , Multiple Sclerosis*/drug therapy , Multiple Sclerosis*/immunology, Humans ; Tyrosine Kinase Inhibitors

المؤلفون: Zhang L; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, State Key Laboratory of Complex Severe and Rare Diseases, Beijing, China., Gao YH; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, State Key Laboratory of Complex Severe and Rare Diseases, Beijing, China., Li SY; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, State Key Laboratory of Complex Severe and Rare Diseases, Beijing, China., Zhao H; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, State Key Laboratory of Complex Severe and Rare Diseases, Beijing, China., Zhang MY; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, State Key Laboratory of Complex Severe and Rare Diseases, Beijing, China., Yu YY; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, State Key Laboratory of Complex Severe and Rare Diseases, Beijing, China., Liu YT; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, State Key Laboratory of Complex Severe and Rare Diseases, Beijing, China., Li J; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, State Key Laboratory of Complex Severe and Rare Diseases, Beijing, China. lijian@pumch.cn.

المصدر: International journal of hematology [Int J Hematol] 2024 Jun; Vol. 119 (6), pp. 631-637. Date of Electronic Publication: 2024 Mar 28.

نوع المنشور: Journal Article; Clinical Trial

بيانات الدورية: Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-3774 (Electronic) Linking ISSN: 09255710 NLM ISO Abbreviation: Int J Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Castleman Disease*/drug therapy , Pyrimidines*/therapeutic use , Pyrimidines*/administration & dosage , Agammaglobulinaemia Tyrosine Kinase*/antagonists & inhibitors , Pyrazoles*/therapeutic use , Pyrazoles*/administration & dosage , Pyrazoles*/adverse effects , Protein Kinase Inhibitors*/therapeutic use , Protein Kinase Inhibitors*/administration & dosage , Protein Kinase Inhibitors*/adverse effects , Piperidines*/therapeutic use , Piperidines*/administration & dosage, Humans ; Male ; Middle Aged ; Female ; Adult ; Prospective Studies ; Recurrence ; Treatment Outcome ; Aged ; Tyrosine Kinase Inhibitors

SCR Disease Name: Multi-centric Castleman's Disease

المؤلفون: Yuan CT; National Taiwan University Cancer Center., Ma WL; National Taiwan University Hospital.

المصدر: Blood [Blood] 2024 May 16; Vol. 143 (20), pp. 2106.

نوع المنشور: Letter; Case Reports; Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, Mantle-Cell*/genetics , Lymphoma, Mantle-Cell*/drug therapy , Lymphoma, Mantle-Cell*/pathology , Agammaglobulinaemia Tyrosine Kinase*/antagonists & inhibitors , Agammaglobulinaemia Tyrosine Kinase*/genetics , Drug Resistance, Neoplasm*/genetics , Protein Kinase Inhibitors*/therapeutic use, Humans ; Genotype ; Protein-Tyrosine Kinases/genetics ; Protein-Tyrosine Kinases/antagonists & inhibitors ; Male ; Pyrimidines/therapeutic use ; Tyrosine Kinase Inhibitors

المؤلفون: Xiang S; The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, China., Shen R; The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, China., Xiang J; The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, China., Zhu N; The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, China., Gu J; The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, China., Shen J; The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, China., Zhang Y; The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, China., Ge H; The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, China.

المصدر: Expert opinion on drug safety [Expert Opin Drug Saf] 2024 May; Vol. 23 (5), pp. 627-636. Date of Electronic Publication: 2024 Mar 18.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101163027 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-764X (Electronic) Linking ISSN: 14740338 NLM ISO Abbreviation: Expert Opin Drug Saf Subsets: MEDLINE

مواضيع طبية MeSH: Pharmacovigilance* , Adverse Drug Reaction Reporting Systems*/statistics & numerical data , Agammaglobulinaemia Tyrosine Kinase*/antagonists & inhibitors , Protein Kinase Inhibitors*/adverse effects , Protein Kinase Inhibitors*/administration & dosage , Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Antineoplastic Combined Chemotherapy Protocols*/administration & dosage , United States Food and Drug Administration*, Humans ; United States ; Adenine/analogs & derivatives ; Adenine/adverse effects ; Adenine/administration & dosage ; Lenalidomide/administration & dosage ; Lenalidomide/adverse effects ; Piperidines/administration & dosage ; Piperidines/adverse effects ; Sulfonamides/administration & dosage ; Sulfonamides/adverse effects ; Databases, Factual ; Tyrosine Kinase Inhibitors ; Bridged Bicyclo Compounds, Heterocyclic

المؤلفون: Salles G; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chen JMH; PRECISIONheor, Vancouver, BC, Canada. jenny.chen@precisionvh.com., Zhang I; PRECISIONheor, Oakland, CA, USA., Kerbauy F; Federal University of Sao Paulo and Beneficência Portuguesa de São Paulo, São Paulo, Brazil., Wu JJ; Kite, a Gilead Company, Santa Monica, CA, USA., Wade SW; Wade Outcomes Research and Consulting, Salt Lake City, UT, USA., Nunes A; Kite, a Gilead Company, Santa Monica, CA, USA., Feng C; Kite, a Gilead Company, Santa Monica, CA, USA., Kloos I; Kite, a Gilead Company, Santa Monica, CA, USA., Peng W; Kite, a Gilead Company, Santa Monica, CA, USA., Snider JT; Kite, a Gilead Company, Santa Monica, CA, USA., Maciel D; PRECISIONheor, Vancouver, BC, Canada., Chan K; PRECISIONheor, Vancouver, BC, Canada., Keeping S; PRECISIONheor, Vancouver, BC, Canada., Shah B; Moffitt Cancer Center, Tampa, FL, USA.

المصدر: Advances in therapy [Adv Ther] 2024 May; Vol. 41 (5), pp. 1938-1952. Date of Electronic Publication: 2024 Mar 18.

نوع المنشور: Journal Article; Comparative Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, Mantle-Cell*/drug therapy , Agammaglobulinaemia Tyrosine Kinase*/antagonists & inhibitors , Pyrimidines*/therapeutic use, Humans ; Male ; Female ; Middle Aged ; Aged ; Protein Kinase Inhibitors/therapeutic use ; Piperidines/therapeutic use ; Immunotherapy, Adoptive/methods ; Adult ; Aged, 80 and over ; Tyrosine Kinase Inhibitors